Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Title
Grant Type
Focus Area
Country
Application Due Date
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple Myeloma
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
PARP-inhibitor Combination Treatments in Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Approaches to Increase Equitable Access to and Delivery of Quality of Care with BsAb for Patients with Mutiple Myeloma
Release Date:
Partner: International Myeloma Foundation
Review Process: Expert Review Panel
Quality Improvement Oncology All
Improving the care and outcomes of Canadians living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Committing to Support Elderly Cancer Patients
Release Date:
Partner: Japan Society of Clinical Oncology
Review Process: Expert Review Panel
Education Oncology Japan
Establishing System for Early Detection of Atrial Fibrillation and Prevention of Cardioembolic Stroke
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Japan
Improving Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Promoting Understanding of Maternal Immunization
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Promoting Understanding of Pneumonia Prevention
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Treatment Environment of Appropriate antiviral therapy for COVID-19 Infections
Release Date:
Review Process: Pfizer Internal
Education Hospital Japan